Company No: 13856139 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2026		2025
		£		£
Fixed assets		699		1,407
Current assets		108,532		124,077
Prepayments and accrued income		26,086		24,222
Creditors: amounts falling due within one year		( 238,984)		( 236,376)
Net current liabilities		( 104,366)		( 88,077)
Total assets less current liabilities		( 103,667)		( 86,670)
Accruals and deferred income		( 3,733)		( 3,908)
Net liabilities		( 107,400)		( 90,578)
Capital and reserves		( 107,400)		( 90,578)

For the financial year ending 28 February 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Elenjical Solutions International Limited (registered number: 13856139) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

T S Elenjical Director

02 June 2026

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 13856139). The address of its registered office is First Floor, 5 Fleet Place, London, EC4M 7RD, United Kingdom.

2. Employees

	2026		2025
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	3		3